We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Medical News & Perspectives |

Sequencing of the Malaria Genome Opens Door to Vaccines and New Drugs

Joan Stephenson, PhD
JAMA. 2002;287(10):1251-1253. doi:10.1001/jama.287.10.1251.
Text Size: A A A
Published online


Las Vegas—The deadly scourge of malaria, a malady mentioned on clay tablets by members of an ancient civilization in 4000 BC, is yielding its secrets to 21st-century scientists who have virtually completed a 6-year effort to sequence the genome of the parasite responsible for the deadliest form of the infection.

Sequencing the Plasmodium falciparum genome—comprising approximately 5000 to 6000 genes in 14 chromosomes—has been a formidable challenge, according to the international team who decoded the genome and provided a preview of their work here at the Second Conference on Microbial Genomes, cosponsored by the American Society of Microbiology and by The Institute for Genomic Research (TIGR). Now, they say, the effort is beginning to pay off, as important information from this work is made available to malaria researchers who are seeking to create vaccines and antimalarial drugs.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

The sequencing of the genomes of the malaria parasite and of its mosquito vector (Anopheles gambiae) is expected to transform research on a disease that is lethal to millions. (Photo credit: CDC/James D. Gathany)

Graphic Jump Location



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Multivalent and multipathogen vaccines delivered by viral vectors. Clin Vaccine Immunol Published online Aug 17, 2016;